Huawei plans for more AI pharma tie-ups, says healthcare president
Kort samengevat
SHANGHAI — Chinese technology conglomerate Huawei plans to expand its AI co-operation with local pharmaceutical firms into drug development and clinical practice, a senior executive said.The move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are investing in modelling tools and automated laboratories to shorten development timelines and improve efficiency."As we...
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij AsiaOne.
Lees het volledige bericht ↗